Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2007-12-12
2011-11-29
Tran, Susan (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S423000, C424S484000, C424S489000, C424S490000
Reexamination Certificate
active
08067020
ABSTRACT:
A composition comprises a protein, a polyol, and a metal. The protein is stabilized by the polyol and the metal, and is protected from denaturing when in contact with an organic solvent. The polyol may be a hydrocarbon containing two or more hydroxyl groups (—OH) bonded to carbon. The metal may be divalent.
REFERENCES:
patent: 4016273 (1977-04-01), Sieger et al.
patent: 4297344 (1981-10-01), Schwinn et al.
patent: 4938763 (1990-07-01), Dunn et al.
patent: 4975271 (1990-12-01), Dunn et al.
patent: 5077049 (1991-12-01), Dunn et al.
patent: 5096885 (1992-03-01), Pearlman et al.
patent: 5133981 (1992-07-01), Harkrader et al.
patent: 5242910 (1993-09-01), Damanj
patent: 5278201 (1994-01-01), Dunn et al.
patent: 5278202 (1994-01-01), Dunn et al.
patent: 5324519 (1994-06-01), Dunn et al.
patent: 5324520 (1994-06-01), Dunn et al.
patent: 5340849 (1994-08-01), Dunn et al.
patent: 5368859 (1994-11-01), Dunn et al.
patent: 5411951 (1995-05-01), Mitchell
patent: 5487897 (1996-01-01), Polson et al.
patent: 5556905 (1996-09-01), Frappier et al.
patent: 5589167 (1996-12-01), Cleland et al.
patent: 5591713 (1997-01-01), Igari et al.
patent: 5599552 (1997-02-01), Dunn et al.
patent: 5651986 (1997-07-01), Brem et al.
patent: 5665394 (1997-09-01), Igari et al.
patent: 5747058 (1998-05-01), Tipton et al.
patent: 5780044 (1998-07-01), Yewey et al.
patent: 5783205 (1998-07-01), Berggren et al.
patent: 5851229 (1998-12-01), Lentz et al.
patent: 5889035 (1999-03-01), Strupczewski et al.
patent: 5912015 (1999-06-01), Bernstein et al.
patent: 5945115 (1999-08-01), Dunn et al.
patent: 5968542 (1999-10-01), Tipton
patent: 5972370 (1999-10-01), Eckenhoff et al.
patent: 5981489 (1999-11-01), Stevenson et al.
patent: 6039977 (2000-03-01), Venkatraman et al.
patent: 6051259 (2000-04-01), Johnson et al.
patent: 6051558 (2000-04-01), Burns et al.
patent: 6066619 (2000-05-01), Stevenson et al.
patent: 6080429 (2000-06-01), Cleland et al.
patent: 6087324 (2000-07-01), Igari et al.
patent: 6110503 (2000-08-01), Rickey et al.
patent: 6113943 (2000-09-01), Okada et al.
patent: 6113947 (2000-09-01), Cleland et al.
patent: 6120789 (2000-09-01), Dunn
patent: 6124261 (2000-09-01), Stevenson et al.
patent: 6130200 (2000-10-01), Brodbeck et al.
patent: 6143314 (2000-11-01), Chandrashekar et al.
patent: 6146662 (2000-11-01), Jao et al.
patent: 6165508 (2000-12-01), Tracy et al.
patent: 6174547 (2001-01-01), Dong et al.
patent: 6190700 (2001-02-01), Okada et al.
patent: 6191107 (2001-02-01), Yamagata et al.
patent: 6197350 (2001-03-01), Yamagata et al.
patent: 6245806 (2001-06-01), Dombrowski et al.
patent: 6267958 (2001-07-01), Andya et al.
patent: 6328979 (2001-12-01), Yamashita et al.
patent: 6413536 (2002-07-01), Gibson et al.
patent: 6429296 (2002-08-01), Yamagata et al.
patent: 6719992 (2004-04-01), Jeng et al.
patent: 6992065 (2006-01-01), Okumu
patent: 7318931 (2008-01-01), Okumu et al.
patent: 7340226 (2008-03-01), Ben-Ayun et al.
patent: 2001/0002263 (2001-05-01), Yamagata et al.
patent: 2002/0001631 (2002-01-01), Okumu
patent: 2003/0045454 (2003-03-01), Okumu et al.
patent: 2325554 (1999-03-01), None
patent: 2 316 485 (1999-07-01), None
patent: 0 216 485 (1987-04-01), None
patent: 0216485 (1987-04-01), None
patent: 0216485 (1987-04-01), None
patent: 0351296 (1990-01-01), None
patent: 0389177 (1990-09-01), None
patent: 0 501 375 (1992-09-01), None
patent: 0484387 (1994-01-01), None
patent: 0633020 (1994-07-01), None
patent: 1060741 (2000-12-01), None
patent: 1274459 (2005-11-01), None
patent: 1 456 433 (1976-11-01), None
patent: 62-257990 (1987-11-01), None
patent: 2023866 (1990-01-01), None
patent: 7227282 (1995-08-01), None
patent: T H08-507064 (1996-07-01), None
patent: A H11-158200 (1999-06-01), None
patent: T H11-507278 (1999-06-01), None
patent: WO 89/03671 (1989-05-01), None
patent: WO 90/03768 (1990-04-01), None
patent: WO 91/05544 (1991-05-01), None
patent: WO 92/17200 (1992-10-01), None
patent: WO 92/17200 (1992-10-01), None
patent: WO 9217200 (1992-10-01), None
patent: WO 94/12158 (1994-06-01), None
patent: WO 94/19020 (1994-09-01), None
patent: WO 96/03116 (1996-02-01), None
patent: WO 96/18417 (1996-06-01), None
patent: WO 96/39995 (1996-12-01), None
patent: WO 96/40072 (1996-12-01), None
patent: WO 96/40073 (1996-12-01), None
patent: WO 96/40074 (1996-12-01), None
patent: WO 98/27962 (1998-07-01), None
patent: WO 98/27963 (1998-07-01), None
patent: WO 98/53837 (1998-12-01), None
patent: WO 99/33491 (1998-12-01), None
patent: WO 99/48479 (1999-09-01), None
patent: WO 00/38652 (2000-07-01), None
patent: WO 00/38652 (2000-07-01), None
patent: WO 0038652 (2000-07-01), None
patent: WO 00/78335 (2000-12-01), None
patent: WO 01/28524 (2001-04-01), None
patent: WO 01/78683 (2001-10-01), None
US 5,849,884, 12/1998, Woiszwillo et al. (withdrawn)
Bartus et al., “Sustained delivery of proteins for novel therapeutic products”, Science, United States, vol. 281, No. 5380, pp. 1161-1162, Aug. 21, 1998.
Bartus, R.T., et al.: “Sustained delivery of proteins for novel therapeutic agents.” Science. United States Aug. 21, 1998, vol. 281, No. 5380, pp. 1161-1162.
Smith, D.A., et al.: “A novel parenteral delivery system”, Pharm. Research, NY, NY, US, vol. 13, No. 3, 1996, p. 300 XP001041946, ISSN: 0724-8741.
Gray et al., “Cloning of Human Tumor Necrosis Factor (TNF) Receptor cDNA and Expression of Recombinant Soluble TNF-Binding Protein”, Proc.Natl. Acad. Sci. USA, 87, 7380-7384, (1990).
Kohno et al., “A Second Tumor Necrosis Factor Receptor Gene Product Can Shed a Naturally Occurring Tumor Necrosis Factor Inhibitor”, Proc.Natl. Acad. Sci. USA, 87, 8331-8335, (1990).
Arakawa et al., “Protein-Solvent Interactions in Pharmaceutical Formulations”,Pharmaceutical Research, 8, No. 3, 285-291, (1991).
Timasheff, S.N., “The Control of Protein Stability and Association by Weak Interactions with Water: How Do Solvents Affect These Processes?”Annu. Rev. Biophys. Biomol. Struct., 22, pp. 67-97, (1993).
Kita et al., “Contribution of the Surface Free Energy Perturbation to Protein-Solvent Interactions”,Biochemistry, 33, 15178-15189, (1994).
Timasheff, S.N., “Solvent Stabilization of Protein Structure”,Methods in Molecular Biology, 40, 253-269, (1995).
Johnson et al., “A Month-Long Effect From a Single Injection of Microencapsulated Human Growth Hormone”,Nature Medicine, 2, No. 7, 795-799, (1996).
Lin et al., “On the Role of Surface Tension in the Stabilization of Globular Proteins”,Protein Science, 5, 372-381, (1996).
Xie et al., “The Thermodynamic Mechanism of Protein Stabilization by Trehalose”,Biophysical Chemistry, 64, 25-43, (1997).
Maa at al., “Spray-Drying of Air-Liquid Interface Sensitive Recombinant Human Growth Hormone”,Journal of Pharmaceutical Sciences, 87, No. 2, 152-159, (1998).
Timasheff, S.N., “Control of Protein Stability and Reactions by Weakly Interacting Cosolvents: The Simplicity of the Complicated”,Advances in Protein Chemistry, 51, 355-432, (1998).
Sackett et al., “Multivalent Cations Depress Ligand Binding to Cell-Associated Insulin-Like Growth Factor Binding Protein-5 on Human Glioblastoma Cells”,Endocrinology, 139, No. 4, 1943-1951, (1998).
Lai et al., “Metal and RNA Binding Properties of the hdm2 Ring Finger Domain”,Biochemistry, 37, No. 48, 17005-17015, (1998).
Yang et al., “Effect of Zinc Binding and Precipitation on Structures of Recombinant Human Growth Hormone and Nerve Growth Factor”,Journal of Pharmaceutical Sciences, 89, No. 11, 1480-1485, (2000).
U.S. Appl. No. 60/214,168, filed Jun. 26, 2000.
Handbook of Chemistry and Physics, “Viscosity of Liquids”, David R. Lide, Editor, 72ndEdition, p. 6-159, 1991-1992.
“Crodesta Sugar Esters, Sucrose fatty acid esters”, Croda, Personal Care, pp. 1-4, Feb. 8, 2000.
International Search Report for PCT application No. PCT/US01/12909 dated Dec. 27, 2001.
Notice of Rejection for JP2003-506926 dated
Cleland Jeffrey L.
Okumu Franklin
Evan Law Group LLC
Genetech, Inc.
Tran Susan
LandOfFree
Sustained release formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained release formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained release formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4288325